Tag: convention center

Pioneering Global Presence, Empowering the World – Zuowei Technology Shining at WHX Miami Medical Expo

SHENZHEN, China, July 1, 2025 /PRNewswire/ -- From June 11 to 13, the 2025 WHX Miami Medical Expo (formerly known as FIME), the annual grand event...

[Anime Expo 2025] NOMELON NOLEMON (tsumiki and MIKIMARIA) to Perform Live During “Mobile Suit Gundam GQuuuuuuX” Panel Livestream

Onsite Free Giveaway and GUNDAM CARD GAME Promotional Tie-In Details Revealed LOS ANGELES, June 30, 2025 /PRNewswire/ -- Today, Bandai Namco Filmworks Inc. announced the...

Fabrix.ai’s Enterprise-grade Agentic AI Platform Generates Strong Interest at Cisco Live’25

Fabrix.ai Successfully Demonstrated AI-Powered Network Operations and Autonomous Agents; Cisco Validated Zone Showcase Draws customer attention PLEASANTON, Calif., June 26, 2025 /PRNewswire/ -- Fabrix.ai (...

Questex’s Sensors Converge and Fierce Electronics Announce 2025 Best of Sensors Awards Winners

Honors Innovation, Leadership, and Excellence Driving the Future of Sensors, Electronics, and AI

Honors Innovation, Leadership, and Excellence Driving the Future of Sensors, Electronics, and AI

Iconic Beginnings: Legacies in Motion

103 Years of Bringing Native Art to the World SANTA FE, N.M., June 25, 2025 /PRNewswire/ -- The Southwestern Association for Indian Arts (SWAIA) is...

Celebrate the Wonderfully Weird: The Oddities and Curiosities Expo Descends on New Orleans

Enjoy a showcase of all things weird. NEW ORLEANS, June 24, 2025 /PRNewswire/ -- Brace yourselves for the strangest and most exciting event of the year...

Ceva Launches MotionEngine™ Hex: Bringing Precise, Touch-Free, Spatial Control to Smart TV, Gaming, and IoT Interfaces

MotionEngine Hex software fuses UWB and motion sensor data to deliver 6-degree-of-freedom (6-DOF) motion tracking and intuitive control, enabling new interaction paradigms for electronic displays ROCKVILLE,...

Vitafoods Asia 2025 Is Ready to Connect Nutraceutical World This September

BANGKOK, June 24, 2025 /PRNewswire/ -- In an era where consumers are becoming more health-conscious and proactive about their well-being, the nutraceutical industry has...

Novo Nordisk A/S: Ozempic® receives EU recommendation in peripheral arterial disease, cementing the broad benefits of semaglutide for people with type 2 diabetes and...

Bagsværd, Denmark, 23 June 2025 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of the Ozempic^® (once-weekly semaglutide) label to reflect the positive data from the STRIDE peripheral artery disease (PAD) functional outcomes trial.

Molex Introduces TrackLabel BLE Printable Asset Labels with Real-Time Location Sensing to Enhance Supply Chain Visibility, Logistics and Inventory Monitoring

Versatile smart label combines thinnest form factor, peel-and-stick design and patent-pending activation to facilitate flexible, fast placement and easy operationSeamless integration with Bluetooth Low-Energy...

Toshiba Showcases Innovative SCiB™ Lithium-Ion Battery at ASIA Sustainable Energy Week 2025

Empowering Greener Transport, Logistics, and Infrastructure for a Decarbonized Future BANGKOK, June 23, 2025 /PRNewswire/ -- Toshiba Corporation announces its participation in ASIA Sustainable Energy Week 2025...

Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data...

Bagsværd, Denmark, 22 June 2025 – Novo Nordisk today presented results from the phase 3b FRONTIER5 trial showing that a direct switch to investigational Mim8 (denecimig) prophylaxis from emicizumab treatment, without a washout period or Mim8 loading dose, was well-tolerated with no safety concerns in adults and adolescents living with haemophilia A, with or without inhibitors¹. Additionally, a FRONTIER5 Patient-Reported Outcomes (PROs) assessment found the Mim8 pen-injector easy to use, with an overall strong user preference for the pen-injector compared to the previous emicizumab injection system^2,3. The results were presented at the International Society on Thrombosis and Haemostasis (ISTH) Congress in Washington, D.C.

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the...

New FRONTIER5 results show a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated...

MetaVia Presents Pre-Clinical Data on DA-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the ADA’s 85th Scientific Session

CAMBRIDGE, Mass., June 21, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the presentation of...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsConvention center

US $1,000 quick loan No Credit Check Loans: Radcred Launches Instant Bad Credit Loans For Emergency Need

Myanmar Construction Industry Report 2025 | Output to Register an AAGR of 3.9% During 2026-2029, Supported by Investments in Renewable Energy, Infrastructure Projects, and...

Middlefield Canadian Income PCC – Dividend Declaration